Stephen R. Bertenshaw
G. D. Searle & Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen R. Bertenshaw.
Bioorganic & Medicinal Chemistry Letters | 1996
Stephen R. Bertenshaw; John J. Talley; Donald J. Rogier; Matthew J. Graneto; Carol M. Koboldt; Yan Zhang
Abstract Benzothiopyranopyrazoles and benzopyranopyrazoles containing either a sulfone or sulfonamide moiety were synthesized and tested for COX-1 and COX-2 inhibition. This new class of COX-2 selective inhibitors possess antiinflammatory activity in vivo.
Bioorganic & Medicinal Chemistry Letters | 1995
Stephen R. Bertenshaw; John J. Talley; Donald J. Rogier; Matthew J. Graneto; Roland S. Rogers; Steven W. Kramer; Thomas D. Penning; Carol M. Koboldt; Amy W. Veenhuizen; Yan Zhang; William E. Perkins
Abstract A group of 3,4-diarylthiophenes containing either a sulfone or sulfonamide moiety were synthesized and tested for COX-1 and COX-2 inhibition. They are selective inhibitors of COX-2 and possess antiinflammatory activity in vivo .
Medicinal Research Reviews | 1999
John J. Talley; Stephen R. Bertenshaw; David L. Brown; Jeffery S. Carter; Mathew J. Graneto; Carol M. Koboldt; Jaime L. Masferrer; Bryan H. Norman; D. Joseph Rogier; Ben S. Zweifel; Karen Seibert
A series of methysulfonyl or sulfonamido substituted 4,5‐diaryloxazole were prepared and evaluated for their ability to inhibit the inducible form of cyclooxygenase (COX‐2) in vitro and in vivo. Several unique substitution patterns were identified that led to potent and selective inhibitors of COX‐2. In general, 2‐trifluoromethly‐4,5‐diaryloxazoles substituted with a methylsulfonyl or sulfonamido group were particularly potent inhibitors. One of the more potent compounds with a selectivity for COX‐2 of about 800 fold was 4b (SC‐299). SC‐299, a highly fluorescent molecule, may be useful for spectroscopic studies on preferential inhibitor binding to COX‐2.
Journal of Medicinal Chemistry | 1997
Thomas D. Penning; John J. Talley; Stephen R. Bertenshaw; Jeffery S. Carter; Paul W. Collins; Stephen H Docter; Matthew J. Graneto; Len F. Lee; James W. Malecha; Julie M. Miyashiro; Roland S. Rogers; Donald J. Rogier; Stella S. Yu; Gary D. Anderson; Earl G. Burton; J. Nita Cogburn; Susan A. Gregory; Carol M. Koboldt; William Perkins; Karen Seibert; Amy W. Veenhuizen; and Yan Y. Zhang; Peter C. Isakson
Archive | 1993
John J. Talley; Thomas D. Penning; Paul W. Collins; Donald J. Rogier; James W. Malecha; Julie M. Miyashiro; Stephen R. Bertenshaw; Ish K. Khanna; Matthew J. Graneto; Roland S. Rogers; Jeffery S. Carter
Archive | 1994
John J. Talley; Thomas D. Penning; Paul W. Collins; Donald J. Rogier; James W. Malecha; Julie M. Miyashiro; Stephen R. Bertenshaw; Ish K. Khanna; Matthew J. Graneto; Roland S. Rogers; Jeffery S. Carter; Stephen H Docter; Stella S. Yu
Archive | 1998
John J. Talley; James W. Malecha; Stephen R. Bertenshaw; Matthew J. Graneto; Jeffery S. Carter; Jinglin Li; Srinivasan Nagarajan; David L. Brown; Donald J. Rogier; Thomas D. Penning; Ish K. Khanna; Xiangdong Xu; Richard M. Weier
Archive | 1998
Jeffery S. Carter; Mark G. Obukowicz; Balekudru Devadas; John J. Talley; David L. Brown; Matthew J. Graneto; Stephen R. Bertenshaw; Donald J. Rogier; Srinivasan Nagarajan; Cathleen E Hanau; Susan J. Hartmann; Cindy L Ludwig; Suzanne Metz
Archive | 1994
John J. Talley; Stephen R. Bertenshaw; Paul W. Collins; Thomas D. Penning; David B. Reitz; Roland S. Rogers
Archive | 1999
Jeffery S. Carter; Mark G. Obukowicz; Balekudru Devadas; John J. Talley; David L. Brown; Matthew J. Graneto; Stephen R. Bertenshaw; Donald J. Rogier; Srinivasan Nagarajan; Cathleen E Hanau; Susan J. Hartmann; Cindy L Ludwig; Suzanne Metz; Donald E. Korte